• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of peritonitis, hospital days, and technique survival for peritoneal dialysis patients in a managed care setting.管理式医疗环境中腹膜透析患者腹膜炎、住院天数和技术存活的预测因素。
Perit Dial Int. 2014 Mar-Apr;34(2):171-8. doi: 10.3747/pdi.2012.00165. Epub 2013 Oct 1.
2
Peritoneal Dialysis-Related Infection Rates and Outcomes: Results From the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).腹膜透析相关感染率和结局:来自腹膜透析结局和实践模式研究(PDOPPS)的结果。
Am J Kidney Dis. 2020 Jul;76(1):42-53. doi: 10.1053/j.ajkd.2019.09.016. Epub 2020 Jan 10.
3
Outcome and complications in peritoneal dialysis patients: a five-year single center experience.腹膜透析患者的结局与并发症:一项为期五年的单中心经验
Saudi J Kidney Dis Transpl. 2011 Mar;22(2):245-51.
4
Albumin at the start of peritoneal dialysis predicts the development of peritonitis.腹膜透析开始时的白蛋白水平可预测腹膜炎的发生。
Am J Kidney Dis. 2003 Mar;41(3):664-9. doi: 10.1053/ajkd.2003.50128.
5
Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.墨西哥西部单一中心持续性非卧床腹膜透析患者及技术生存率
Rev Invest Clin. 2007 May-Jun;59(3):184-91.
6
Peritoneal dialysis in Tunisia: complications, technique and patient's survival (twenty-seven years of experience in a single center).突尼斯的腹膜透析:并发症、技术和患者的生存(单中心 27 年经验)。
Pan Afr Med J. 2021 Jul 7;39:179. doi: 10.11604/pamj.2021.39.179.29354. eCollection 2021.
7
How to improve survival in geriatric peritoneal dialysis patients.如何提高老年腹膜透析患者的生存率。
Perit Dial Int. 2007 Jun;27 Suppl 2:S185-9.
8
Peritoneal Dialysis-Associated Peritonitis Trends Using Medicare Claims Data, 2013-2017.腹膜透析相关性腹膜炎趋势分析:基于 2013-2017 年医疗保险索赔数据
Am J Kidney Dis. 2023 Feb;81(2):179-189. doi: 10.1053/j.ajkd.2022.07.010. Epub 2022 Sep 12.
9
Peritonitis: Episode Sequence, Microbiological Variation, Risk Factors and Clinical Outcomes in a North China Peritoneal Dialysis Center.腹膜炎:中国北方腹膜透析中心的发病过程、微生物学变化、危险因素及临床结局
Kidney Blood Press Res. 2018;43(5):1573-1584. doi: 10.1159/000494443. Epub 2018 Oct 22.
10
Clinical outcomes and mortality in peritoneal dialysis patients: a 10-year retrospective analysis in a single center.腹膜透析患者的临床结局与死亡率:单中心10年回顾性分析
Clin Nephrol. 2013 Oct;80(4):270-9. doi: 10.5414/CN107711.

引用本文的文献

1
Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology-Peritoneal Dialysis Consensus Workshop Report.建立腹膜透析相关性腹膜炎的核心结局指标:肾脏病学-腹膜透析标准化结局共识研讨会报告
Kidney Int Rep. 2022 May 26;7(8):1737-1744. doi: 10.1016/j.ekir.2022.05.020. eCollection 2022 Aug.
2
Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis.从腹膜透析转为血液透析后的死亡率趋势
Kidney Int Rep. 2022 Mar 4;7(5):1062-1073. doi: 10.1016/j.ekir.2022.02.016. eCollection 2022 May.
3
Diabetes Is the Most Critical Risk Factor of Adverse Complications After Peritoneal Dialysis Catheter Placement.糖尿病是腹膜透析置管术后不良并发症的最关键危险因素。
Front Med (Lausanne). 2021 Oct 27;8:719345. doi: 10.3389/fmed.2021.719345. eCollection 2021.
4
Long-term trends in the incidence of peritoneal dialysis-related peritonitis disclose an increasing relevance of streptococcal infections: A longitudinal study.长期趋势在腹膜透析相关腹膜炎的发病率揭示链球菌感染的相关性增加:一项纵向研究。
PLoS One. 2020 Dec 21;15(12):e0244283. doi: 10.1371/journal.pone.0244283. eCollection 2020.
5
Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients.中心型肥胖与虚弱对腹膜透析患者临床结局的交互作用。
PLoS One. 2020 Oct 26;15(10):e0241242. doi: 10.1371/journal.pone.0241242. eCollection 2020.
6
Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients.血清神经酰胺 1-磷酸水平与腹膜透析患者腹膜炎。
Ren Fail. 2020 Nov;42(1):829-835. doi: 10.1080/0886022X.2020.1805763.
7
Transition Between Different Renal Replacement Modalities: Gaps in Knowledge and Care-The Integrated Research Initiative.不同肾脏替代模式之间的转换:知识与照护差距——综合研究倡议
Perit Dial Int. 2019 Jan-Feb;39(1):4-12. doi: 10.3747/pdi.2017.00242.
8
National Trends in Emergency Room Visits of Dialysis Patients for Adverse Drug Reactions.全国范围内透析患者因药物不良反应而急诊就诊的趋势。
Am J Nephrol. 2018;47(6):441-449. doi: 10.1159/000489703. Epub 2018 Jun 12.
9
Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study.接受腹膜透析的HIV合并终末期肾衰竭患者的腹膜炎结局:一项前瞻性队列研究
BMC Nephrol. 2017 Feb 3;18(1):48. doi: 10.1186/s12882-017-0466-0.
10
Lower Education Level Is a Risk Factor for Peritonitis and Technique Failure but Not a Risk for Overall Mortality in Peritoneal Dialysis under Comprehensive Training System.在综合培训体系下的腹膜透析中,低教育水平是腹膜炎和技术失败的危险因素,但不是总体死亡率的危险因素。
PLoS One. 2017 Jan 5;12(1):e0169063. doi: 10.1371/journal.pone.0169063. eCollection 2017.

本文引用的文献

1
Determinants of peritoneal dialysis technique failure in incident US patients.美国新进入腹膜透析患者腹膜透析技术失败的决定因素。
Perit Dial Int. 2013 Mar-Apr;33(2):155-66. doi: 10.3747/pdi.2011.00233. Epub 2012 Oct 2.
2
ISPD position statement on reducing the risks of peritoneal dialysis-related infections.国际腹膜透析学会关于降低腹膜透析相关感染风险的立场声明。
Perit Dial Int. 2011 Nov-Dec;31(6):614-30. doi: 10.3747/pdi.2011.00057. Epub 2011 Aug 31.
3
Family income and survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): time to revisit a myth?巴西腹膜透析多中心研究患者的家庭收入与生存情况(BRAZPD):是时候重新审视一个神话了吗?
Clin J Am Soc Nephrol. 2011 Jul;6(7):1676-83. doi: 10.2215/CJN.09041010. Epub 2011 Jun 23.
4
Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study.患者和医生对腹膜透析技术失败的预测因素:基于人群的回顾性队列研究。
Perit Dial Int. 2011 Sep-Oct;31(5):565-73. doi: 10.3747/pdi.2010.00096. Epub 2010 Oct 14.
5
Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease.终末期肾病患者血液透析和腹膜透析的效果相似。
Arch Intern Med. 2011 Jan 24;171(2):110-8. doi: 10.1001/archinternmed.2010.352. Epub 2010 Sep 27.
6
Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives.腹膜透析的临床结局:持续质量改进措施的影响
Adv Perit Dial. 2009;25:76-9.
7
Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database.腹膜透析患者腹膜炎的预测因素:来自加拿大一个大型前瞻性数据库的结果
Clin J Am Soc Nephrol. 2009 Jul;4(7):1195-200. doi: 10.2215/CJN.00910209. Epub 2009 Apr 30.
8
Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study.从腹膜透析转为血液透析的时机、原因、预测因素及预后:一项前瞻性研究。
BMC Nephrol. 2009 Feb 6;10:3. doi: 10.1186/1471-2369-10-3.
9
Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years' experience in a single center.土耳其腹膜透析患者的生存情况、技术生存率及影响死亡率的因素:单中心12年经验
Perit Dial Int. 2008 May-Jun;28(3):238-45.
10
Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.墨西哥西部单一中心持续性非卧床腹膜透析患者及技术生存率
Rev Invest Clin. 2007 May-Jun;59(3):184-91.

管理式医疗环境中腹膜透析患者腹膜炎、住院天数和技术存活的预测因素。

Predictors of peritonitis, hospital days, and technique survival for peritoneal dialysis patients in a managed care setting.

作者信息

Kumar Victoria A, Sidell Margo A, Yang Wan-Ting, Jones Jason P

机构信息

Department of Internal Medicine,1 Division of Nephrology, Southern California Permanente Medical Group, Los Angeles, and Research and Evaluation,2 Southern California Permanente Medical Group, Pasadena, California, USA.

出版信息

Perit Dial Int. 2014 Mar-Apr;34(2):171-8. doi: 10.3747/pdi.2012.00165. Epub 2013 Oct 1.

DOI:10.3747/pdi.2012.00165
PMID:24084841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3968102/
Abstract

INTRODUCTION

Many clinicians perceive that peritoneal dialysis (PD) should be reserved for younger, healthier, more affluent patients. Our aim was to examine outcomes for PD patients in a managed care setting and to identify predictors of adverse outcomes.

METHODS

We identified all patients who initiated PD at our institution between 1 January 2001 and 31 December 2010. Predictor variables studied included age, sex, race, PD modality, cause of end-stage renal disease (ESRD), dialysis vintage, Charlson comorbidity index (CCI) score, education, and income level. Poisson models were used to determine the relative risk (RR) of peritonitis and the number of hospital days per patient-year. The log-rank test was used to compare technique survival by patient strata.

RESULTS

Among the 1378 patients who met the inclusion criteria, only female sex [RR: 0.85; 95% confidence interval (CI): 0.74 to 0.98; p = 0.02] and higher education (RR: 0.77; 95% CI: 0.60 to 0.98; p = 0.04) were associated with peritonitis. For hospital days, dialysis vintage (RR: 1.11; 95% CI: 1.04 to 1.18; p = 0.002), CCI score (RR: 1.06; 95% CI: 1.02 to 1.20; p = 0.002), and cause of ESRD (RR for glomerulonephritis: 0.59; 95% CI: 0.43 to 0.80; p = 0.0006; and RR for hypertension: 0.69; 95% CI: 0.55 to 0.88; p = 0.002) were associated with 1 extra hospital day per patient-year. The 2-year technique survival was 61% for patients who experienced at least 1 episode of peritonitis and 72% for those experiencing no peritonitis (p = 0.0001). Baseline patient age, primary cause of ESRD, and PD modality were the only other variables associated with technique survival in the study.

CONCLUSIONS

Neither race nor socio-economic status predicted technique survival or hospital days in our study. Female sex and higher education were the only two variables studied that had an association with peritonitis.

摘要

引言

许多临床医生认为腹膜透析(PD)应仅用于更年轻、更健康、更富裕的患者。我们的目的是研究在管理式医疗环境中PD患者的治疗结果,并确定不良结果的预测因素。

方法

我们确定了2001年1月1日至2010年12月31日期间在我们机构开始进行PD治疗的所有患者。研究的预测变量包括年龄、性别、种族、PD治疗方式、终末期肾病(ESRD)的病因、透析时间、查尔森合并症指数(CCI)评分、教育程度和收入水平。采用泊松模型确定腹膜炎的相对风险(RR)以及每位患者每年的住院天数。采用对数秩检验比较不同患者分层的技术生存率。

结果

在符合纳入标准的1378例患者中,只有女性[RR:0.85;95%置信区间(CI):0.74至0.98;p = 0.02]和高等教育程度(RR:0.77;95%CI:0.60至0.98;p = 0.04)与腹膜炎相关。对于住院天数,透析时间(RR:1.11;95%CI:1.04至1.18;p = 0.002)、CCI评分(RR:1.06;95%CI:1.02至1.20;p = 0.002)和ESRD的病因(肾小球肾炎的RR:0.59;95%CI:0.43至0.80;p = 0.0006;高血压的RR:0.69;⑨5%CI:0.55至0.88;p = 0.002)与每位患者每年多1天的住院时间相关。经历至少1次腹膜炎发作的患者2年技术生存率为61%,未经历腹膜炎的患者为72%(p = 0.0001)。基线患者年龄、ESRD的主要病因和PD治疗方式是该研究中与技术生存率相关的仅有的其他变量。

结论

在我们的研究中,种族和社会经济地位均不能预测技术生存率或住院天数。女性和高等教育程度是所研究的仅有的两个与腹膜炎相关的变量。